153 related articles for article (PubMed ID: 30310276)
1. Determination of dose enhancement caused by AuNPs with Xoft
Shahhoseini E; Ramachandran P; Patterson WR; Geso M
Int J Nanomedicine; 2018; 13():5733-5741. PubMed ID: 30310276
[TBL] [Abstract][Full Text] [Related]
2. Measurement of dose enhancement factor for Xoft Axxent electronic brachytherapy device using nanoparticle-embedded alginate film and radiochromic film.
Kakade NR; Das A; Kumar R; Sharma SD; Maiti N; Chadha R; Sapra BK
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147944
[TBL] [Abstract][Full Text] [Related]
3. Effect of Gold Nanoparticle Radiosensitization on Plasmid DNA Damage Induced by High-Dose-Rate Brachytherapy.
Yogo K; Misawa M; Shimizu M; Shimizu H; Kitagawa T; Hirayama R; Ishiyama H; Furukawa T; Yasuda H
Int J Nanomedicine; 2021; 16():359-370. PubMed ID: 33469290
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the effects of cell model and subcellular location of gold nanoparticles on nuclear dose enhancement factors using Monte Carlo simulation.
Cai Z; Pignol JP; Chattopadhyay N; Kwon YL; Lechtman E; Reilly RM
Med Phys; 2013 Nov; 40(11):114101. PubMed ID: 24320476
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Axxent-Xoft, (192)Ir and (60)Co high-dose-rate brachytherapy sources for image-guided brachytherapy treatment planning for cervical cancer.
Mobit PN; Packianathan S; He R; Yang CC
Br J Radiol; 2015 Aug; 88(1052):20150010. PubMed ID: 25996576
[TBL] [Abstract][Full Text] [Related]
6. A detailed Monte Carlo evaluation of
Gray T; Bassiri N; David S; Patel DY; Stathakis S; Kirby N; Mayer KM
Phys Med Biol; 2020 Jul; 65(13):135007. PubMed ID: 32434159
[TBL] [Abstract][Full Text] [Related]
7. Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement.
Ngwa W; Makrigiorgos GM; Berbeco RI
Phys Med Biol; 2010 Nov; 55(21):6533-48. PubMed ID: 20959684
[TBL] [Abstract][Full Text] [Related]
8. Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-Ray Source: an electronic brachytherapy source.
Rivard MJ; Davis SD; DeWerd LA; Rusch TW; Axelrod S
Med Phys; 2006 Nov; 33(11):4020-32. PubMed ID: 17153382
[TBL] [Abstract][Full Text] [Related]
9. Xoft Axxent electronic brachytherapy: a new device for delivering brachytherapy to the breast.
Dickler A
Nat Clin Pract Oncol; 2009 Mar; 6(3):138-42. PubMed ID: 19174776
[TBL] [Abstract][Full Text] [Related]
10. Tumor dose enhancement by nanoparticles during high dose rate (192)Ir brachytherapy.
Zabihzadeh M; Arefian S
J Cancer Res Ther; 2015; 11(4):752-9. PubMed ID: 26881513
[TBL] [Abstract][Full Text] [Related]
11. Applications of tissue heterogeneity corrections and biologically effective dose volume histograms in assessing the doses for accelerated partial breast irradiation using an electronic brachytherapy source.
Shi C; Guo B; Cheng CY; Eng T; Papanikolaou N
Phys Med Biol; 2010 Sep; 55(18):5283-97. PubMed ID: 20720283
[TBL] [Abstract][Full Text] [Related]
12. Accelerated brachytherapy with the Xoft electronic source used in association with iodine, gold, bismuth, gadolinium, and hafnium nano-radioenhancers.
Mesbahi A; Rajabpour S; Smilowitz HM; Hainfeld JF
Brachytherapy; 2022; 21(6):968-978. PubMed ID: 36002350
[TBL] [Abstract][Full Text] [Related]
13. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
Mille MM; Xu XG; Rivard MJ
Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
[TBL] [Abstract][Full Text] [Related]
14. The dependence of radiation enhancement effect on the concentration of gold nanoparticles exposed to low- and high-LET radiations.
Liu Y; Liu X; Jin X; He P; Zheng X; Dai Z; Ye F; Zhao T; Chen W; Li Q
Phys Med; 2015 May; 31(3):210-8. PubMed ID: 25651760
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of brachytherapy sources for high-dose-rate treatment of endometrial cancer: (192)Ir, (60)Co and an electronic brachytherapy source.
Mobit PN; Nguyen A; Packianathan S; He R; Yang CC
Br J Radiol; 2016; 89(1059):20150449. PubMed ID: 26743941
[TBL] [Abstract][Full Text] [Related]
16. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy.
Dickler A; Kirk MC; Seif N; Griem K; Dowlatshahi K; Francescatti D; Abrams RA
Brachytherapy; 2007; 6(2):164-8. PubMed ID: 17434111
[TBL] [Abstract][Full Text] [Related]
17. Effect of gold nanoparticles on radiation doses in tumor treatment: a Monte Carlo study.
Al-Musywel HA; Laref A
Lasers Med Sci; 2017 Dec; 32(9):2073-2080. PubMed ID: 28948388
[TBL] [Abstract][Full Text] [Related]
18. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.
Chattopadhyay N; Cai Z; Kwon YL; Lechtman E; Pignol JP; Reilly RM
Breast Cancer Res Treat; 2013 Jan; 137(1):81-91. PubMed ID: 23160926
[TBL] [Abstract][Full Text] [Related]
19. Breast radiotherapy with kilovoltage photons and gold nanoparticles as radiosensitizer: An in vitro study.
Tudda A; Donzelli E; Nicolini G; Semperboni S; Bossi M; Cavaletti G; Castriconi R; Mangili P; Vecchio AD; Sarno A; Mettivier G; Russo P
Med Phys; 2022 Jan; 49(1):568-578. PubMed ID: 34778990
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles as dose-enhancement agent for kilovoltage X-ray therapy of melanoma.
Kim SR; Kim EH
Int J Radiat Biol; 2017 May; 93(5):517-526. PubMed ID: 28044470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
